Literature DB >> 19031378

Lamotrigine-associated reversible severe hepatitis: a case report.

Adeline Ngo Su-Yin1, Winnie W Tai, Kent R Olson.   

Abstract

INTRODUCTION: Anticonvulsant hypersensitivity syndrome is a severe idiosyncratic reaction to antiepileptic drugs. We report a case of a woman with lamotrigine-associated hepatitis who recovered spontaneously with supportive treatment. CASE REPORT: A 43-year-old woman was being treated with oxcarbazepine for depression and was started on lamotrigine 2 weeks prior to her presentation. The patient then developed nausea and a generalized pruritic macular rash, and was found to have elevated liver enzymes, which peaked at AST, 6079 IU/L; ALT, 6900 IU/L; total bilirubin, 3.9 mg/dL(66.7 micromol/L); alkaline phosphatase, 149 IU/L; international normalized ration (INR), 1.9. The patient showed no signs of encephalopathy and her clinical examination was essentially normal except for very mild jaundice and a diffuse erythematous pruritic macular rash. The patient was hydrated and managed with supportive care. On the third day of hospitalization, her liver enzymes had improved substantially and she was discharged. At follow-up 1 month later the patient's liver enzymes were within the normal range. DISCUSSION: We hypothesize that lamotrigine was directly responsible for the patient's rash and liver impairment given the time sequence of drug introduction and resolution of symptoms and liver enzyme abnormality once the drug was withdrawn. The patient suffered severe transaminitis when lamotrigine was added to oxcarbazepine, which resolved after termination of the medication and supportive management. We recommend monitoring the hepatic function in patients who have just been initiated on lamotrigine, especially if they develop jaundice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19031378      PMCID: PMC3550118          DOI: 10.1007/bf03161210

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  20 in total

1.  Acute hepatic failure in a child treated with lamotrigine.

Authors:  R Arnon; D DeVivo; A R Defelice; P G Kazlow
Journal:  Pediatr Neurol       Date:  1998-03       Impact factor: 3.372

2.  Influence of oxcarbazepine and methsuximide on lamotrigine concentrations in epileptic patients with and without valproic acid comedication: results of a retrospective study.

Authors:  T W May; B Rambeck; U Jürgens
Journal:  Ther Drug Monit       Date:  1999-04       Impact factor: 3.681

3.  Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk.

Authors:  N H Shear; S P Spielberg
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

4.  Fulminant hepatic failure induced by lamotrigine.

Authors:  A J Makin; S Fitt; R Williams; J S Duncan
Journal:  BMJ       Date:  1995-07-29

5.  Multisystem adverse reaction to lamotrigine.

Authors:  J E Schaub; P J Williamson; E W Barnes; P N Trewby
Journal:  Lancet       Date:  1994-08-13       Impact factor: 79.321

6.  Adding lamotrigine to valproate: incidence of rash and other adverse effects. Postmarketing Antiepileptic Drug Survey (PADS) Group.

Authors:  E Faught; G Morris; M Jacobson; J French; C Harden; G Montouris; W Rosenfeld
Journal:  Epilepsia       Date:  1999-08       Impact factor: 5.864

7.  A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

Authors:  J R Calabrese; C L Bowden; G S Sachs; J A Ascher; E Monaghan; G D Rudd
Journal:  J Clin Psychiatry       Date:  1999-02       Impact factor: 4.384

Review 8.  Lamotrigine-associated rash: risk/benefit considerations in adults and children.

Authors:  A H Guberman; F M Besag; M J Brodie; J M Dooley; M S Duchowny; J M Pellock; A Richens; R S Stern; E Trevathan
Journal:  Epilepsia       Date:  1999-07       Impact factor: 5.864

9.  [Oxcarbazepine and DRESS syndrome: a paediatric cause of acute liver failure].

Authors:  E Bosdure; A Cano; B Roquelaure; R Reynaud; M Boyer; L Viard; J Sarles
Journal:  Arch Pediatr       Date:  2004-09       Impact factor: 1.180

Review 10.  Lamotrigine-associated anticonvulsant hypersensitivity syndrome.

Authors:  R G Schlienger; S R Knowles; N H Shear
Journal:  Neurology       Date:  1998-10       Impact factor: 9.910

View more
  2 in total

1.  Analgesic, antiallodynic, and anticonvulsant activity of novel hybrid molecules derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide in animal models of pain and epilepsy.

Authors:  Anna Rapacz; Krzysztof Kamiński; Jolanta Obniska; Paulina Koczurkiewicz; Elżbieta Pękala; Barbara Filipek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-02-10       Impact factor: 3.000

2.  An Epileptic Patient with Recurrent Hyperbilirubinemia Caused by Gilbert Syndrome.

Authors:  Yaoyao Zhang; Yongli Jiang; Fang Yuan; Changgeng Song; Zhihan Zhao; Wen Jiang
Journal:  Case Rep Gastroenterol       Date:  2020-01-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.